Clinical Trials Browser

Phase 2 × Carcinoma, Non-Small-Cell Lung × STA 9090 × Clear all

NCT01031225 2014-09-19

A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms